Clinical Trial Update: A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of cyclosporin ophthalmic gel for moderate to severe dry eye disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Cyclosporin Ophthalmic Gel (cyclosporin)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Moderate to Severe Dry Eye | Phase 3 | Status: RECRUITING